Rimidi

Jan 06, 2021

Boston Medical Center Receives Support from Gilead Sciences to Improve Care for High-Risk Patients Living with Non-Alcoholic Fatty Liver Disease

Aug 13, 2020

Rimidi, LifeQ Partner to Add Wearable-Based Monitoring to Rimidi's Platform Enabling Early Warning of COVID-19 Infection

Mar 06, 2020

Rimidi Unveils New App to Accelerate Patient Screenings for COVID-19

Oct 09, 2019

Rimidi Tackles Obesity Epidemic by Adding Specialized Disease View to its EHR-Integrated Platform

Jul 10, 2019

Rimidi Expands its Cloud-Based Platform to Include Cardiovascular Disease

Mar 11, 2019

Rimidi Partners with Cellular Scale Company, Yields Promising Results for Heart Failure Management

Nov 01, 2018

PTS Diagnostics Enters Co-Branded Agreement With Rimidi

Aug 30, 2018

The Kinetix Group Partners with Rimidi to Launch a Clinical Care Partnership for the Management of Nonalcoholic Steatohepatitis (NASH)

Aug 27, 2018

Rimidi Announces Addition of Jim Clifford as Vice President of Strategic Sales

Jul 10, 2018

Rimidi Closes $6.575 Million Series A with Strategic Investment from Eli Lilly

Jan 09, 2018

Rimidi Appoints Josh Claman as Chief Executive Officer

Dec 14, 2017

Rimidi and Lilly Collaborate to Personalize Solutions for People Using Insulin